STING1 and neoplasm: Injection of 3′3′-cGAMP into mice with either chronic lymphocytic leukaemia or multiple myeloma resulted in apoptosis and tumour regression, implicating the ability of STING agonists to directly eradicate malignant B cells alongside their immunostimulatory functions [77].